NGMedical GmbH, a leading innovator in spinal motion preservation technology, reports significant growth in 2025
NONNWEILER, SAARLAND, GERMANY, February 23, 2026 /EINPresswire.com/ — NGMedical reports another year of double-digit growth. In 2025 revenue grew 43 % above the previous year after 90 % growth in 2024. The biggest contribution to the successful development is MOVE®-C, the first and only articulating viscoelastic artificial disc. MOVE®-C sales grew by 60 % in 2025 above 2024.
In 2025 NGMedical could expand the sales network to 25 countries with product approvals amongst others in the USA, Australia and Mexico. MOVE®-C exceeded the significant milestone of 5,000 implants with excellent, up to 6 years, clinical results.
“With our focus on motion preservation and next generation implants like MOVE®-C and MOVE®-P, we are able to continue double-digit growth year over year. Unique products and a great team as well as excellent partners allow us to achieve such a wonderful development.” said Peter Weiland, CEO at NGMedical.
In 2026 NGMedical will further expand its sales network worldwide and achieve product approvals in important markets like Brazil. MOVE®-C continues to be the growth driver.
For more information about the MOVE®-C prosthesis and the entire product portfolio, please visit our webpage https://ngmedical.de/en/.
About NGMedical
We are an owner-managed company specializing in the development of innovative spinal implants. Many years of experience, combined with a high degree of creativity, give us the impetus to significantly advance the development of spine surgery. Scientific research, intensive mechanical tests and clinical control are the basis a of great out-come.
NGMedical pushes the limits of motion preserving spine treatment. Our focus lays on motion preserving technologies like the unique MOVE®-C and the advanced lumbar concept of MOVE®-P and is completed by state-of-the-art fusion products. Market changing developments made in Germany.
Peter Weiland
NGMedical GmbH
+49 6873999970
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
